Lung Cancer
FDA approves first-line combination for EGFR-mutant non-small cell lung cancer
The FDA approved amivantamab-vmjw plus lazertinib as first-line treatment for certain adults with non-small cell lung cancer.
Healio Minute Podcast, Lung Cancer Edition: Top Headlines - Week of August 12, 2024
In this edition, low education level raises follow-up risk in screening program, screening judgement strongly influenced by clinicians and more.
Lung cancer trial halted due to lack of survival benefit, higher toxicity
A randomized phase 3 trial designed to compare two combinations for first-line treatment of lung cancer has been halted after an interim analysis revealed no survival benefit and more toxicity with the experimental regimen.
Nearly half of adults with new small lung nodules feel distressed, anxious
Among adults with newly identified small pulmonary nodules, 48.8% reported emotional distress and 42.3% reported general anxiety, according to results published in CHEST.
Low education level raises risk for loss to follow-up in lung cancer screening program
Having an education level of high school or less heightened the risk for loss to follow-up among individuals eligible for lung cancer screening, according to a letter published in Annals of the American Thoracic Society.
Lung cancer screening judgement strongly influenced by clinicians
During lung cancer screening selection assessments, clinicians influenced the decision of screening inappropriateness more than patient factors, according to results published in American Journal of Respiratory and Critical Care Medicine.
World Lung Cancer Day: Risks of vaping; an ‘unprecedented’ advance in ALK-positive disease
Today is World Lung Cancer Day.
Blood biomarker identifying benign lung nodules performs well across subgroups
A blood biomarker used to identify benign vs. malignant pulmonary nodules displayed “excellent” performance regardless of sex, smoking status, screen detection and nodule size, according to a research letter published in CHEST.
Occupational benzene exposure heightens lung cancer likelihood
Having been exposed to benzene during work heightened the odds for lung cancer development, according to results published in American Journal of Respiratory and Critical Care Medicine.